MedTrace Logo

Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing Chemotherapy

NCT03098277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2025-06-25

No results posted yet for this study

Summary

This clinical trial studies movement tracking devices in optimizing and monitoring physical activity in patients with solid tumors undergoing chemotherapy in a health care facility during the day without spending the night. Movement tracking devices, such as Microsoft Kinect 2 and Microsoft Band 2, may help doctors learn about the health of cancer patients.

Conditions

  • Solid Neoplasm

Interventions

OTHER

Accelerometer

Wear Microsoft Band 2

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Physical Activity Measurement

Perform physical activities recorded by Microsoft Kinect 2

BEHAVIORAL

Telephone-Based Intervention

Complete PRO questionnaires

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Jorge Nieva · University of Southern California

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-06
Primary Completion
2018-03-12
Completion
2019-02-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03098277 on ClinicalTrials.gov